Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carlsson

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
BMC Infectious Diseases|February 9, 2010
Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosisIvar Tjernberg, Martin Carlsson, Jan Ernerudh, et al.
The Journal of Sexual Medicine|May 14, 2018
Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With PlaceboJohn P Mulhall, Martin Carlsson, Vera Stecher, et al.
Current Medical Research and Opinion|April 5, 2007
Onset of efficacy of tolterodine extended release in patients with overactive bladderDavid O Sussman, Stephen R Kraus, Martin Carlsson, et al.
BJU International|June 8, 2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladderRoger Dmochowski, Karl Kreder, Scott MacDiarmid, et al.
BMC Medical Research Methodology|July 24, 2009
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladderSoyon Lee, Bimal Malhotra, Dana Creanga, et al.
Neurourology and Urodynamics|May 26, 2021
What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodineAdrian S Wagg, Sender Herschorn, Martin Carlsson, et al.
Journal of Comparative Effectiveness Research|July 26, 2022
A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladderAdrian S Wagg, Sender Herschorn, Martin Carlsson, et al.
Drug, Healthcare and Patient Safety|April 10, 2019
Adherence to risk management guidelines for drugs which cause vitamin D deficiency - big data from the Swedish health systemOla Nordqvist, Ulrika Lönnbom Svensson, Lars Brudin, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 2, 2016
Erythrocyte fatty acid composition does not influence levels of free, bioavailable, and total 25-hydroxy vitamin DMartin Carlsson, Ingela Nilsson, Lars Brudin, et al.
Sexual Medicine Reviews|March 26, 2017
Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord InjuryDana A Ohl, Martin Carlsson, Vera J Stecher, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
BMC Infectious Diseases|February 9, 2010
Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosisIvar Tjernberg, Martin Carlsson, Jan Ernerudh, et al.
The Journal of Sexual Medicine|May 14, 2018
Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With PlaceboJohn P Mulhall, Martin Carlsson, Vera Stecher, et al.
Current Medical Research and Opinion|April 5, 2007
Onset of efficacy of tolterodine extended release in patients with overactive bladderDavid O Sussman, Stephen R Kraus, Martin Carlsson, et al.
BJU International|June 8, 2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladderRoger Dmochowski, Karl Kreder, Scott MacDiarmid, et al.
BMC Medical Research Methodology|July 24, 2009
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladderSoyon Lee, Bimal Malhotra, Dana Creanga, et al.
Neurourology and Urodynamics|May 26, 2021
What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodineAdrian S Wagg, Sender Herschorn, Martin Carlsson, et al.
Journal of Comparative Effectiveness Research|July 26, 2022
A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladderAdrian S Wagg, Sender Herschorn, Martin Carlsson, et al.
Drug, Healthcare and Patient Safety|April 10, 2019
Adherence to risk management guidelines for drugs which cause vitamin D deficiency - big data from the Swedish health systemOla Nordqvist, Ulrika Lönnbom Svensson, Lars Brudin, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 2, 2016
Erythrocyte fatty acid composition does not influence levels of free, bioavailable, and total 25-hydroxy vitamin DMartin Carlsson, Ingela Nilsson, Lars Brudin, et al.
Sexual Medicine Reviews|March 26, 2017
Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord InjuryDana A Ohl, Martin Carlsson, Vera J Stecher, et al.
Pageof 6